
Shree Ganesh Remedies Ltd is Rated Sell
2026-11-21 10:10:04Shree Ganesh Remedies Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 17 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 November 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read More
Shree Ganesh Remedies Ltd is Rated Sell
2026-11-10 10:10:04Shree Ganesh Remedies Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 17 August 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 10 November 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.
Read More
Shree Ganesh Remedies Ltd is Rated Sell
2026-10-30 10:10:24Shree Ganesh Remedies Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 17 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 30 October 2026, providing investors with the most recent and relevant data to assess the company’s prospects.
Read More
Shree Ganesh Remedies Ltd Sees Technical Momentum Shift Amid Mixed Indicator Signals
2026-10-29 08:02:50Shree Ganesh Remedies Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish stance. Despite a modest day gain of 0.23%, the stock’s technical indicators present a complex picture, with some metrics signalling caution while others suggest potential for upside. This article analyses the recent technical parameter changes, price momentum, and key indicator signals to provide a comprehensive view for investors.
Read More
Shree Ganesh Remedies Ltd Shows Bullish Technical Momentum Amid Mixed Indicators
2026-10-28 08:05:12Shree Ganesh Remedies Ltd has exhibited a notable shift in price momentum, transitioning from a mildly bullish to a bullish technical trend. Despite a mixed bag of indicator signals, the micro-cap pharmaceutical company’s recent price action and technical parameters suggest a cautiously optimistic outlook for investors, even as its MarketsMOJO grade remains at Sell.
Read More
Shree Ganesh Remedies Ltd Sees Mixed Technical Signals Amid Price Momentum Shift
2026-10-22 08:06:15Shree Ganesh Remedies Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a recent downgrade in its Mojo Grade to Sell from Strong Sell, the stock’s year-to-date returns remain robust, outperforming the Sensex by a significant margin.
Read More
Shree Ganesh Remedies Ltd is Rated Sell
2026-10-19 10:10:04Shree Ganesh Remedies Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 17 August 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 19 October 2026, providing investors with the latest insights into its performance and outlook.
Read More
Shree Ganesh Remedies Ltd Sees Bullish Momentum Amid Technical Upgrades
2026-10-16 08:04:41Shree Ganesh Remedies Ltd has exhibited a notable shift in price momentum, moving from a mildly bullish to a bullish technical trend, supported by key indicators such as MACD and moving averages. Despite some bearish signals on the monthly RSI, the stock’s recent performance and technical parameters suggest a cautiously optimistic outlook for investors in the Pharmaceuticals & Biotechnology sector.
Read More
Shree Ganesh Remedies Ltd Sees Mixed Technical Signals Amid Price Momentum Shift
2026-10-14 08:06:07Shree Ganesh Remedies Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical parameters, reflecting a complex interplay of bullish and bearish signals. Despite a recent downgrade in its Mojo Grade to 'Sell' from 'Strong Sell', the stock’s price momentum and technical indicators present a nuanced picture for investors navigating the current market environment.
Read MoreAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
18-Nov-2026 | Source : BSETranscript of Earnings Conference Call
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
14-Nov-2026 | Source : BSEAudio Recording - Earnings Call held on November 14 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
11-Nov-2026 | Source : BSEIntimation for invitation of Earnings Conference Call
Corporate Actions
No Upcoming Board Meetings
Shree Ganesh Remedies Ltd has declared 5% dividend, ex-date: 07 Sep 23
No Splits history available
Shree Ganesh Remedies Ltd has announced 1:5 bonus issue, ex-date: 01 Nov 21
Shree Ganesh Remedies Ltd has announced 7:100 rights issue, ex-date: 03 Feb 23